4//SEC Filing
Afsarmanesh Nasim 4
Accession 0001209191-22-035483
CIK 0000804753other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:20 PM ET
Size
9.8 KB
Accession
0001209191-22-035483
Insider Transaction Report
Form 4
CERNER CorpCERN
Afsarmanesh Nasim
EVP & Chief Health Officer
Transactions
- Disposition to Issuer
Restricted Stock Units
2022-06-08−8,024→ 0 totalFrom: 2023-03-04Exp: 2025-03-04→ Common Stock (8,024 underlying) - Disposition to Issuer
Restricted Stock Units
2022-06-08−6,444→ 0 totalFrom: 2023-02-24Exp: 2025-02-24→ Common Stock (6,444 underlying)
Holdings
- 0
Common Stock
Footnotes (2)
- [F1]This Form 4 reports derivative securities disposed of pursuant to the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle.
- [F2]At the Effective Time, each unvested restricted stock unit ("RSU") was assumed by Oracle and converted into a number of Oracle RSUs based on the Award Exchange Ratio (as defined in the Merger Agreement), on the same vesting terms, all in accordance with the Merger Agreement. Each RSU that vested on the Effective Time was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement) in accordance with the Merger Agreement. The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K.
Documents
Issuer
CERNER Corp
CIK 0000804753
Entity typeother
Related Parties
1- filerCIK 0001903726
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:20 PM ET
- Size
- 9.8 KB